KRRO

Korro Bio, Inc. - Common Stock (KRRO)

About Korro Bio, Inc. - Common Stock (KRRO)

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Details

Daily high

$17.00

Daily low

$15.93

Price at open

52 Week High

$36.79

52 Week Low

$5.20

Market cap

233.5M

Dividend yield

Volume

803

Avg. volume

226,755

P/E ratio

-1.58

Korro Bio, Inc. - Common Stock News